NEWS COMMENTARY

Corteva invests in Lavie Bio, the ag subsidiary of Evogene

Published:
August 15, 2019
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Strategy
by Joshua Haslun
Very important

Corteva received a 30% equity stake in Lavie Bio as well as certain undisclosed rights to the company's corn and soy pipelines, and Evogene acquired Taxon Biosciences, a microbial genomics and gene discovery platform developer Corteva acquired in 2015. This strategic move passes Taxon's technologies on to Lavie Bio, but Corteva retains some access through it stake. Corteva continues to advance consumer access to biologicals, mainly through partnerships (outside of livestock solutions), as evidenced by this and its recent partnership with Stoller Group. The strategy allows Corteva to focus resources on its development pipeline, while Lavie gains a massive new market in Corteva's corn and soy customers for its future biologicals.

For the original news article, click here .


Further Reading

Seed tech startup Inari likely to reach commercialization with completion of $89 million Series C round

News Commentary | August 07, 2019

The venture parent, Flagship Pioneering, was joined by the Investment Corporation of Dubai, EDBI, and VC Acre Venture Partners in the round. The company's previous rounds went toward the development of its seed foundry and access to a variety of genomic technologies. This funding will provide the ... To read more, click here.

Corteva expands relationship with Evogene through new AgPlenus relationship

News Commentary | March 27, 2020

The multiyear collaboration leverages Evogene's digital framework to identify novel herbicide candidates or exploit known leads. AgPlenus claims 10 potential leads with novel modes of action in its pipeline. Corteva's relationship to Evogene now spans the company's ag input product development ... Not part of subscription

AI-driven crop protection discovery startup Enko Chem raises $45 million Series B

News Commentary | June 26, 2020

Led by the Bill & Melinda Gates Foundation and joined by six other investors, the round brings Enko Chem's total funding to $66 million in three years. Enko will advance its discovery efforts toward finding alternatives to existing insecticides, fungicides, and herbicides. Enko's discovery ... Not part of subscription